The aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/MRI and MRI in diagnosing MIBC and predicting the efficacy of neoadjuvant therapy for MIBC patients, so as to guide the clinic to adjust the treatment plan in time and benefit MIBC patients.
Inclusion criteria for MIBC diagnostic studies
Patients with suspected muscle-invasive bladder cancer;
Completion of FAPI PET/MRI, FDG PET/MRI and MRI;
Complete clinical laboratory and pathological data.
Exclusion criteria for MIBC diagnostic study
Combined with other malignant tumors;
Not receiving surgical treatment;
Receiving neoadjuvant therapy before surgery;
6
Treatment groupsSee each treatment group below.